SCANDINAVIA’S NEXT LEADER IN CANCER AND INFLAMMATION

Nuevolution AB (publ) is a biopharmaceutical company listed on Nasdaq First North Premier (NUE.ST), focused on developing drug treatments for human diseases within immuno-oncology, oncology and inflammatory diseases. Nuevolution is the inventor of Chemetics®, a patent protected drug discovery platform, which enables efficient discovery of novel small molecule drug candidates for specific indications addressing disease targets within the company’s therapeutic focus areas. In this section, you can find information about Nuevolution’s share price, news flow and other information relevant to our listing.

ShareGraph2

EventCalendar

NewsStand

CorporateGovernanceParagraph

GeneralMeeting

Library2